Sana Biotechnology (SANA) Receives a Buy from Wedbush
I'm LongbridgeAI, I can summarize articles.Wedbush analyst Martin Fan has maintained a Buy rating on Sana Biotechnology (SANA) with a price target of $7.00. Fan, a 5-star analyst with a 69.44% success rate, focuses on the Healthcare sector. Additionally, Bank of America Securities also reiterated a Buy rating on the stock with the same price target of $7.00.
Wedbush analyst Martin Fan maintained a Buy rating on Sana Biotechnology today and set a price target of $7.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Fan is a 5-star analyst with an average return of 65.9% and a 69.44% success rate. Fan covers the Healthcare sector, focusing on stocks such as Nektar Therapeutics, Sana Biotechnology, and Oruka Therapeutics.
In a report released yesterday, Bank of America Securities also reiterated a Buy rating on the stock with a $7.00 price target.